In the last 12 months, insiders at Arcturus Therapeutics Holdings Inc. ($ARCT) filed 87 transactions with the SEC: 2 open-market purchases totaling $40,998 and 20 sales totaling $7,043,715. Net insider sentiment: net selling.
Arcturus Therapeutics Holdings Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Chivukula Pad (Chief Scientific Officer & COO) — 20 transactions totaling $5,001,977
- SASSINE ANDY (Chief Financial Officer) — 6 transactions totaling $1,663,746
- Kummerfeld Keith C (See Remarks) — 15 transactions totaling $565,055
- HOLMES EDWARD W (Director) — 6 transactions totaling $0
- FARRELL PETER C (Director) — 6 transactions totaling $0
View all SEC Filings for Arcturus Therapeutics Holdings Inc. (ARCT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 17, 2025 | Chivukula Pad | Chief Scientific Officer & COO | A | Employee Stock Option (right to buy) | 54000 | $0.00 | 54,000.0000 | 28,412,537 | 9999.99% | 0.19% |
| Dec. 17, 2025 | Roberts Joseph | Controller | A | Employee Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 28,412,537 | 9999.99% | 0.04% |
| Dec. 17, 2025 | Kurata Lance | Chief Legal Officer | A | Employee Stock Option (right to buy) | 54000 | $0.00 | 54,000.0000 | 28,412,537 | 9999.99% | 0.19% |
| Dec. 17, 2025 | Payne Joseph E | President and CEO | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 28,412,537 | 9999.99% | 0.62% |
| Aug. 15, 2025 | SASSINE ANDY | Chief Financial Officer | P | Common Stock | 1238 | $16.56 | 221,764.0000 | 27,119,823 | 0.56% | 0.00% |
| Aug. 15, 2025 | SASSINE ANDY | Chief Financial Officer | P | Common Stock | 1238 | $16.56 | 221,764.0000 | 27,119,823 | 0.56% | 0.00% |
| June 9, 2025 | Markels John | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 27,119,823 | 9999.99% | 0.06% |
| June 9, 2025 | BARLOW JAMES F | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 27,119,823 | 9999.99% | 0.06% |
| June 9, 2025 | HOLMES EDWARD W | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 27,119,823 | 9999.99% | 0.06% |
| June 9, 2025 | FARRELL PETER C | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 27,119,823 | 9999.99% | 0.06% |
| June 9, 2025 | Slaoui Moncef | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 27,119,823 | 9999.99% | 0.06% |
| June 9, 2025 | Marquet Magda | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 27,119,823 | 9999.99% | 0.06% |
| June 9, 2025 | Marantz Jing L. | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 27,119,823 | 9999.99% | 0.06% |
| Dec. 16, 2024 | Kurata Lance | Chief Legal Officer | A | Employee Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | Payne Joseph E | President and CEO | A | Employee Stock Option (right to buy) | 196000 | $0.00 | 196,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | SASSINE ANDY | Chief Financial Officer | A | Employee Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | Chivukula Pad | Chief Scientific Officer & COO | A | Employee Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 15, 2024 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 12000 | $20.76 | 435,334.0000 | 0 | 2.68% | 0.00% |
| June 19, 2024 | Slaoui Moncef | Director | A | Stock option (right to buy) | 14794 | $0.00 | 14,794.0000 | 0 | 9999.99% | 0.00% |
| June 19, 2024 | Slaoui Moncef | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | FARRELL PETER C | Director | M | Common Stock | 3131 | $0.00 | 98,696.0000 | 0 | 3.28% | 0.00% |
| June 14, 2024 | Marantz Jing L. | Director | M | Common Stock | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Marantz Jing L. | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | HOLMES EDWARD W | Director | M | Common Stock | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | HOLMES EDWARD W | Director | M | Deferred Stock Units | 3131 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 14, 2024 | HOLMES EDWARD W | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Markels John | Director | M | Common Stock | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Markels John | Director | M | Deferred Stock Units | 3131 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 14, 2024 | Markels John | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Marquet Magda | Director | M | Common Stock | 3131 | $0.00 | 28,073.0000 | 0 | 12.55% | 0.00% |
| June 14, 2024 | Marquet Magda | Director | M | Deferred Stock Units | 3131 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 14, 2024 | Marquet Magda | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | BARLOW JAMES F | Director | M | Common Stock | 3131 | $0.00 | 13,131.0000 | 0 | 31.31% | 0.00% |
| June 14, 2024 | BARLOW JAMES F | Director | M | Deferred Stock Units | 3131 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 14, 2024 | BARLOW JAMES F | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | FARRELL PETER C | Director | M | Deferred Stock Units | 3131 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 14, 2024 | FARRELL PETER C | Director | A | Stock option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Marantz Jing L. | Director | M | Deferred Stock Units | 3131 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 12, 2024 | SASSINE ANDY | Chief Financial Officer | S | Common Stock | 50000 | $32.03 | 220,526.0000 | 0 | 18.48% | 0.00% |
| June 5, 2024 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 114 | $45.00 | 447,334.0000 | 0 | 0.03% | 0.00% |
| June 3, 2024 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 26000 | $40.01 | 447,448.0000 | 0 | 5.49% | 0.00% |
| March 25, 2024 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 17435 | $35.02 | 473,448.0000 | 0 | 3.55% | 0.00% |
| March 19, 2024 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 8565 | $35.01 | 490,883.0000 | 0 | 1.71% | 0.00% |
| Dec. 15, 2023 | Payne Joseph E | President and CEO | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2023 | Kummerfeld Keith C | See Remarks | A | Employee Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2023 | Kurata Lance | Chief Legal Officer | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2023 | Chivukula Pad | Chief Scientific Officer & COO | A | Employee Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2023 | SASSINE ANDY | Chief Financial Officer | A | Employee Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 5000 | $18.72 | 499,448.0000 | 0 | 0.99% | 0.00% |
| Oct. 2, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 5000 | $25.61 | 504,448.0000 | 0 | 0.98% | 0.00% |
| Sept. 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 5000 | $31.45 | 509,448.0000 | 0 | 0.97% | 0.00% |
| Aug. 15, 2023 | SASSINE ANDY | Chief Financial Officer | A | Common Stock | 1223 | $17.37 | 270,526.0000 | 0 | 0.45% | 0.00% |
| Aug. 1, 2023 | Marantz Jing L. | Director | A | Stock option (right to buy) | 11869 | $0.00 | 11,869.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Marantz Jing L. | Director | A | Deferred Stock Units | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | HOLMES EDWARD W | Director | A | Stock Option (right to buy) | 11869 | $0.00 | 11,869.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | HOLMES EDWARD W | Director | A | Deferred Stock Units | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | BARLOW JAMES F | Director | A | Stock option (right to buy) | 11869 | $0.00 | 11,869.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | BARLOW JAMES F | Director | A | Deferred Stock Units | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Marquet Magda | Director | A | Stock option (right to buy) | 11869 | $0.00 | 11,869.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Marquet Magda | Director | A | Deferred Stock Units | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Markels John | Director | A | Deferred Stock Units | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | FARRELL PETER C | Director | A | Stock option (right to buy) | 11869 | $0.00 | 11,869.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | FARRELL PETER C | Director | A | Deferred Stock Units | 3131 | $0.00 | 3,131.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Markels John | Director | A | Stock option (right to buy) | 11869 | $0.00 | 11,869.0000 | 0 | 9999.99% | 0.00% |
| Aug. 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 5000 | $34.91 | 514,448.0000 | 0 | 0.96% | 0.00% |
| July 14, 2023 | Kummerfeld Keith C | See Remarks | M | Employee Stock Option (right to buy) | 4500 | $0.00 | 21,000.0000 | 0 | 17.65% | 0.00% |
| July 14, 2023 | Kummerfeld Keith C | See Remarks | M | Employee Stock Option (right to buy) | 1437 | $0.00 | 7,126.0000 | 0 | 16.78% | 0.00% |
| July 14, 2023 | Kummerfeld Keith C | See Remarks | M | Employee Stock Option (right to buy) | 1031 | $0.00 | 7,938.0000 | 0 | 11.50% | 0.00% |
| July 14, 2023 | Kummerfeld Keith C | See Remarks | M | Common Stock | 4500 | $9.04 | 5,450.0000 | 0 | 473.68% | 0.00% |
| July 14, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 25000 | $35.01 | 519,448.0000 | 0 | 4.59% | 0.00% |
| July 14, 2023 | Kummerfeld Keith C | See Remarks | M | Common Stock | 1437 | $4.99 | 6,887.0000 | 0 | 26.37% | 0.00% |
| July 14, 2023 | Kummerfeld Keith C | See Remarks | M | Common Stock | 1031 | $14.12 | 7,918.0000 | 0 | 14.97% | 0.00% |
| July 14, 2023 | Kummerfeld Keith C | See Remarks | S | Common Stock | 6968 | $35.00 | 950.0000 | 0 | 88.00% | 0.00% |
| July 3, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 5000 | $28.75 | 544,448.0000 | 0 | 0.91% | 0.00% |
| June 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 5000 | $27.16 | 549,448.0000 | 0 | 0.90% | 0.00% |
| May 11, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 7925 | $30.24 | 554,448.0000 | 0 | 1.41% | 0.00% |
| May 10, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 17075 | $30.00 | 562,373.0000 | 0 | 2.95% | 0.00% |
| May 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 5000 | $25.93 | 579,448.0000 | 0 | 0.86% | 0.00% |
| April 17, 2023 | Kummerfeld Keith C | See Remarks | M | Employee Stock Option (right to buy) | 4500 | $0.00 | 25,500.0000 | 0 | 15.00% | 0.00% |
| April 17, 2023 | Kummerfeld Keith C | See Remarks | M | Employee Stock Option (right to buy) | 1437 | $0.00 | 8,563.0000 | 0 | 14.37% | 0.00% |
| April 18, 2023 | Kummerfeld Keith C | See Remarks | M | Common Stock | 1031 | $14.12 | 1,981.0000 | 0 | 108.53% | 0.00% |
| April 18, 2023 | Kummerfeld Keith C | See Remarks | M | Common Stock | 4500 | $9.04 | 6,481.0000 | 0 | 227.16% | 0.00% |
| April 18, 2023 | Kummerfeld Keith C | See Remarks | M | Common Stock | 1437 | $4.99 | 7,918.0000 | 0 | 22.17% | 0.00% |
| April 18, 2023 | Kummerfeld Keith C | See Remarks | S | Common Stock | 6968 | $28.18 | 950.0000 | 0 | 88.00% | 0.00% |
| April 17, 2023 | Kummerfeld Keith C | See Remarks | M | Employee Stock Option (right to buy) | 1031 | $0.00 | 8,969.0000 | 0 | 10.31% | 0.00% |
| April 3, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 5000 | $25.38 | 584,448.0000 | 0 | 0.85% | 0.00% |
| March 6, 2023 | Chivukula Pad | Chief Scientific Officer & COO | S | Common Stock | 5000 | $16.07 | 589,448.0000 | 0 | 0.84% | 0.00% |